Arrowstreet Capital
PCRX icon

Arrowstreet Capital’s Pacira BioSciences PCRX Stock Holding History

Arrowstreet Capital’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$835K Sell
36,966
-16,232
-31% -$361K ﹤0.01% 1595
2025
Q4 		$1.38M Buy
53,198
+11,405
+27% +$271K ﹤0.01% 1489
2025
Q3 		$1.08M Buy
41,793
+6,187
+17% +$152K ﹤0.01% 1580
2025
Q2 		$851K Sell
35,606
-31,982
-47% -$806K ﹤0.01% 1650
2025
Q1 		$1.68M Sell
67,588
-579,730
-90% -$13.9M ﹤0.01% 1353
2024
Q4 		$12.2M Sell
647,318
-505,307
-44% -$8.87M 0.01% 766
2024
Q3 		$17.3M Buy
1,152,625
+1,099,216
+2,058% +$18.8M 0.01% 574
2024
Q2 		$1.53M Buy
+53,409
New +$1.52M ﹤0.01% 1138
2017
Q3 		– Sell
-12,000
Closed -$572K – 1199
2017
Q2 		$572K Buy
+12,000
New +$557K ﹤0.01% 860
2015
Q1 		– Sell
-46,160
Closed -$4.09M – 1171
2014
Q4 		$4.09M Sell
46,160
-70,334
-60% -$6.65M 0.02% 501
2014
Q3 		$11.3M Buy
116,494
+90,908
+355% +$8.84M 0.06% 256
2014
Q2 		$2.35M Buy
+25,586
New +$1.95M 0.01% 549

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return